Life Science and Technology
| December 2011 The Hollywood of the Arab World: not just Mummies and Magic Mummies, Pharoahs, Pyramids, locusts, quicksand, and romance. These disparate things may not seem to have any connecon when listed, but they are the component parts of the Hollywood blockbuster. The Mummy (1999), starring Rachel Weisz and Brendan Fraser. The Hollywood thriller used an Egypan backdrop to showcase incredible CGI effects as the main characters interchangeably fled from and fought the traditionally embalmed, but now resurrected corpse of an Ancient Egypan Pharoah. Read more… |
![]() |
| June 2011 Entering the Age of the Smartphone We are at a pivotal point in technology development. Continuous improvement in the technology industry has redefined our daily existence. Absolute reliance on technology has become the norm. Without our GPS devices, e-readers, smartphones, laptops, usb sticks and digital cameras, many of us would have trouble getting through the day. Read More… |
![]() |
| May 2011 Computing is Heading for the Cloud Suddenly everyone in the technology industry is looking to the sky, but instead of reaching for stars companies are reaching for the Cloud. We, the general technology using public, are already relying on some form of cloud computing, whether we realize it or not. Read More… |
![]() |
| August 2010 “Super Bugs” – A threat that can be combated with novel antibiotics? How must Alexander Fleming have felt when, in 1928, he discovered a fungus having destroyed his bacterial cultures? His first instinct might have been disappointment, but he soon realized the impact of his accidental find: he had discovered the first antibiotic, penicillin. Since then, it has become the most widely-used antibiotic; derivatives of it are used even now to successfully treat many of the most common infections. Read more… |
![]() |
|
June 2010
Burn Injuries and their Treatment |
![]() |
|
May 2010
Peptide drugs Peptide drugs have had a difficult history. From being hailed as the “new systemic antibiotic” favour in a little over a decade, owing to several compromising characteristics. In comparison to some small molecules, for example, they are more expensive to manufacture, more difficult to administer and are eliminated more quickly from the blood stream in the early 1990’s, they fell from. Read more…
|
![]() |













